These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 27193602)

  • 1. Bending the Cost Curve in Childhood Cancer.
    Russell H; Bernhardt MB
    Curr Hematol Malig Rep; 2016 Aug; 11(4):295-302. PubMed ID: 27193602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The economics of cancer care in the UK.
    Bosanquet N; Sikora K
    Lancet Oncol; 2004 Sep; 5(9):568-74. PubMed ID: 15337487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mission-oriented translational cancer research - health economics.
    Jönsson B; Sullivan R
    Mol Oncol; 2019 Mar; 13(3):636-647. PubMed ID: 30628161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacoeconomics of cancer therapies: considerations with the introduction of biosimilars.
    Henry D; Taylor C
    Semin Oncol; 2014 Apr; 41 Suppl 3():S13-20. PubMed ID: 24767632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends and issues in oncology costs.
    Scalo JF; Rascati KL
    Expert Rev Pharmacoecon Outcomes Res; 2014 Feb; 14(1):35-44. PubMed ID: 24328809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outpatient cancer drug costs: changes, drivers, and the future.
    Halbert RJ; Zaher C; Wade S; Malin J; Lawless GD; Dubois RW
    Cancer; 2002 Feb; 94(4):1142-50. PubMed ID: 11920485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seeking value as cancer drug costs soar.
    Bender E
    Cancer Discov; 2013 Aug; 3(8):833-4. PubMed ID: 23928760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost analysis of in-patient cancer chemotherapy at a tertiary care hospital.
    Wani MA; Tabish SA; Jan FA; Khan NA; Wafai ZA; Pandita KK
    J Cancer Res Ther; 2013; 9(3):397-401. PubMed ID: 24125973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Forgotten public health impacts of cancer - an overview.
    Viegas S; Ladeira C; Costa-Veiga A; Perelman J; Gajski G
    Arh Hig Rada Toksikol; 2017 Dec; 68(4):287-297. PubMed ID: 29337686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "It's the economy, stupid": strategies for improved cost containment in cancer treatment.
    Sleijfer S
    Clin Pharmacol Ther; 2014 Apr; 95(4):365-7. PubMed ID: 24646487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. United healthcare, five oncology practices try bundled payments.
    Goozner M
    J Natl Cancer Inst; 2011 Jan; 103(1):8-10. PubMed ID: 21169535
    [No Abstract]   [Full Text] [Related]  

  • 13. Changing costs of metastatic non small cell lung cancer in the Netherlands.
    Keusters WR; de Weger VA; Hövels A; Schellens JHM; Frederix GWJ
    Lung Cancer; 2017 Dec; 114():56-61. PubMed ID: 29173766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redesigning Advanced Cancer Care Delivery: Three Ways to Create Higher Value Cancer Care.
    Patel MI; Moore D; Milstein A
    J Oncol Pract; 2015 Jul; 11(4):280-4. PubMed ID: 25991638
    [No Abstract]   [Full Text] [Related]  

  • 15. Financial toxicity in cancer care: Prevalence, causes, consequences, and reduction strategies.
    Lentz R; Benson AB; Kircher S
    J Surg Oncol; 2019 Jul; 120(1):85-92. PubMed ID: 30650186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost of the inpatient management of febrile neutropenia in cancer patients--a micro-costing study in the Irish healthcare setting.
    O'Brien C; Fogarty E; Walsh C; Dempsey O; Barry M; Kennedy MJ; McCullagh L
    Eur J Cancer Care (Engl); 2015; 24(1):125-32. PubMed ID: 24472035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost aspects of palliative cancer care.
    Bailes JS
    Semin Oncol; 1995 Apr; 22(2 Suppl 3):64-6. PubMed ID: 7537906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of economic impact of targeted oral anticancer medications.
    Shen C; Chien CR; Geynisman DM; Smieliauskas F; Shih YC
    Expert Rev Pharmacoecon Outcomes Res; 2014 Feb; 14(1):45-69. PubMed ID: 24378038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacoeconomics and cost of cancer drugs].
    Camps Herrero C; Caballero Díaz C; Blasco Cordellat A
    Farm Hosp; 2010 Mar; 34 Suppl 1():12-5. PubMed ID: 20920852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obstacles to affordable cancer treatments.
    Dusetzina SB; Muluneh B; Khan T; Richards KL; Keating NL
    N C Med J; 2014; 75(4):257-60. PubMed ID: 25046090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.